Kerala Ayurveda Limited has informed the stock exchanges that its board of directors will meet on Monday, May 25, 2026. The primary agenda for the meeting is to consider and approve the audited financial results of the company for the quarter and year ended March 31, 2026.

The board will review the financial performance for both standalone and consolidated operations. This disclosure is made in compliance with Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, the trading window for dealing in the company's securities is currently closed. This restriction applies to designated persons and their immediate relatives.

The trading window closed on March 31, 2026, and will remain shut until 48 hours after the financial results are made public. This measure is intended to prevent insider trading during the period leading up to the results announcement.

Meeting Details

The intimation was signed by George K T, Chief Financial Officer and Designated Officer for filing, on behalf of Kerala Ayurveda Limited.

Kerala Ayurveda Limited has received notification from BSE Limited regarding the rejection of its waiver application for a regulatory fine of ₹5,31,000. The rejection was communicated via email on April 16, 2026, marking the end of the company's attempt to seek relief from the penalty imposed by the stock exchange.

Fine Details and Background

The fine was originally imposed by BSE on August 29, 2025, for non-compliance with board composition requirements under Regulation 17(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The violation period extended from October 1, 2024 to June 30, 2025.

Waiver Application Timeline

Kerala Ayurveda had filed a waiver application with BSE on September 9, 2025, seeking relief from the imposed fine. However, after approximately seven months of consideration, BSE rejected the application on April 16, 2026.

Financial Impact and Company Response

Despite the rejection of its waiver application, Kerala Ayurveda had already remitted the fine amount to BSE Limited under protest on March 10, 2026. The company has indicated that apart from the payment of the fine, there are no other material financial implications arising from this regulatory action.

Regulatory Compliance Disclosure

The company has fulfilled its disclosure obligations under Regulation 30 read with Schedule III of the Listing Regulations, providing detailed information as required by SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026. The disclosure includes comprehensive details about the authority involved, nature of the action, violation specifics, and financial impact assessment.